Michael Dreher1, David Price2,3,4, Asparuh Gardev5, Pascale Peeters6, Satish Arora7, Simone van der Sar-van der Brugge8, Richard Dekhuijzen9, Omar S Usmani10. 1. Department of Pneumology and Intensive Care Medicine, 39058University Hospital Aachen; RWTH Aachen University, Aachen, Germany. 2. Observational and Pragmatic Research Institute, Singapore. 3. Optimum Patient Care, Cambridge, UK. 4. Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. 5. 60325Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany. 6. 54886IQVIA RDS France, La Défense, France. 7. Lambertseter Medical Centre, Oslo, Norway. 8. 89411Amphia Hospital, Breda, The Netherlands. 9. 6029Radboud University Medical Center, Nijmegen, The Netherlands. 10. National Heart and Lung Institute (NHLI), 4615Imperial College London, London, UK.
Abstract
PLAIN LANGUAGE SUMMARY: Inhalers are often used to treat patients with chronic obstructive pulmonary disease (COPD). However, there are many available, which can lead to confusion and poor inhaler technique. It is important for a patient to be happy with their inhaler. This study looked at how patients liked the re-usable Respimat® Soft Mist™ inhaler vs. their previous inhaler. It also asked whether they would be willing to continue using the device at the end of the study period.After 4-6 weeks of using the re-usable device, patients reported that they were happy with the inhaler and most would be willing to carry on using it.Overall, these results show that doctors can prescribe Respimat re-usable to patients, even if the patient has not used the inhaler before.
PLAIN LANGUAGE SUMMARY: Inhalers are often used to treat patients with chronic obstructive pulmonary disease (COPD). However, there are many available, which can lead to confusion and poor inhaler technique. It is important for a patient to be happy with their inhaler. This study looked at how patients liked the re-usable Respimat® Soft Mist™ inhaler vs. their previous inhaler. It also asked whether they would be willing to continue using the device at the end of the study period.After 4-6 weeks of using the re-usable device, patients reported that they were happy with the inhaler and most would be willing to carry on using it.Overall, these results show that doctors can prescribe Respimat re-usable to patients, even if the patient has not used the inhaler before.
Entities:
Keywords:
COPD; PASAPQ; Respimat; ease of handling; preference; switch